What is Nelumbo Nucifera used for?

Nelumbo Nucifera (Nelumbo nucifera) carries a Grade C rating — limited evidence. Strongest recorded design is a randomized controlled trial, drawn from 3 recorded studies, 1 in people. Recorded activity centres on metabolic regulation, stress response modulation and AMPK signaling, which describes mechanism rather than demonstrated benefit. Noted cautions include pregnancy/breastfeeding without clinician supervision and known allergy to the plant/family.

Herb Profile

Nelumbo Nucifera

Nelumbo nucifera

Nelumbo Nucifera (Nelumbo nucifera) carries a Grade C rating — limited evidence.

Last reviewed: June 6, 2026•3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution — May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy. Details

Evidence: Limited Evidence
Typical onset: Varies by prep
Safety rating: High caution
Best for: Sedative, Anti Inflammatory, Antioxidant, Stress
Avoid / review if: Pregnancy/Breastfeeding Without Clinician Supervision, Known Allergy To The Plant/Family, Potential Interaction Concern With Antidiabetic Medicines

Generated profile category visual

At a glance

From this profile's structured data

Evidence: Grade C
Safety: May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.
Profile context: sedative, anti_inflammatory, antioxidant

Next stepsWhere to go next — guides & comparisons

If you want help sleeping → Sleep guides
If you want help with anxiety or stress → Anxiety & stress guides
If you want to browse more herbs → All herbs

Safety

Safety & Cautions

May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

Interaction-AwareMedication or interaction context is explicitly noted.
Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

Pregnancy/Breastfeeding Without Clinician Supervision
Known Allergy To The Plant/Family
Potential Interaction Concern With Antidiabetic Medicines
Immunosuppressants
Use Clinician Review For High Dose Extracts Or Chronic Use.

Safety classifications

Interaction-Aware: Medication or interaction context is explicitly noted.
Pregnancy/Breastfeeding Caution: Pregnancy or breastfeeding caution language is present.

Full safety note

May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

Safety labels

Interaction-Aware
Pregnancy/Breastfeeding Caution

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Moderate Caution

110 flagged pairings

Blood-sugar lowering

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Blood-sugar loweringCertainty: Theoretical

Data provenance recorded for 110 of 110 pairings in this mechanism group.

+98 more pairings share this mechanism. Use the Safety Checker to review a specific combination.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · Stress Response Modulation · AMPK Signaling

Research maturity: Emerging research — Long Term Human Evidence May Be Limited.

Safety boundary: Safety note available — May lower blood glucose or alter metabolic markers; monitor with diabetes medications and avoid unsupervised use during pregnancy.

This profile cites 3 human studies.

Study design details

Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match: Randomized controlled trial
Risk of Bias: Low
Consistency: Not assessed

Strongest recorded design is a randomized controlled trial, drawn from 3 recorded studies, 1 in people.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong: Multiple RCTs, consistent direction, adequate effect size
Moderate: Some RCTs or consistent observational data in humans
Preliminary / Mixed: Animal or in-vitro only, or conflicting human data
Traditional / Theoretical: Traditional use only; no controlled human trials

Clinical Study Summaries (5)1 human evidence source · 1 human trial · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 1 human evidence source; 1 is a human trial. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.

Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned

What would change our conclusion?

Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.

Study	Design	N	Dose	Duration	Population	Outcome	Result & magnitude	Source
A randomized trial in 60 overweight participants reported reductions in some body-fat/body-composition measures after 12 weeks of sun-dried lotus-leaf extract. The sample is small and evidence is extract-specific. Background	Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well.	—	—	—	—	—	A randomized trial in 60 overweight participants reported reductions in some body-fat/body-composition measures after 12 weeks of sun-dried lotus-leaf extract. The sample is small and evidence is extract-specific.	PubMed →
Anti-Aging Potential of Phytoextract Loaded-Pharmaceutical Creams for Human Skin Cell Longetivity Jadoon S et al. · Oxid Med Cell Longev · 2015 Background	Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review.	—	—	—	—	—	—	PubMed →
A review of lotus alkaloids notes low bioavailability and unresolved clinical efficacy/safety, limiting translation from extensive preclinical pharmacology. Background	Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review.	—	—	—	—	—	A review of lotus alkaloids notes low bioavailability and unresolved clinical efficacy/safety, limiting translation from extensive preclinical pharmacology.	PubMed →
Nuciferine Alleviates High-Fat Diet- and ApoE(-/-)-Induced Hepatic Steatosis and Ferroptosis in NAFLD Mice via the PPARα Signaling Pathway Qiu J et al. · J Agric Food Chem · 2024 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →
Effect of Neferine on DNCB-Induced Atopic Dermatitis in HaCaT Cells and BALB/c Mice Yang CC et al. · Int J Mol Sci · 2021 Background	Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.	—	—	—	—	—	—	PubMed →

Dosing & Timing

No standardized dose: Preparation specific; use standardized product label for Preparation varies by tradition and product form and require source backed dosage review before therapeutic claims.

How Nelumbo Nucifera works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Nelumbo Nucifera Works

CompoundTarget / ReceptorMechanismEffect / Outcome

Mechanisms & biological pathways

Preclinical pathways. Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

Metabolic Regulation
Stress Response Modulation
AMPK Signaling
NF KB Modulation

Active Compounds

Key constituents studied in Nelumbo Nucifera, with full pharmacology and safety profiles.

Magnoflorine — active compound in Nelumbo Nucifera

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Nelumbo Nucifera

Condition guides

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Nelumbo Nucifera

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Continue comparing

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Nelumbo Nucifera research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to herbs library Safety checker →

Botanical profile context

How to interpret Nelumbo Nucifera

Nelumbo Nucifera herb profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first… Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Nelumbo Nucifera, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.